DOI: http://dx.doi.org/10.18203/2349-3291.ijcp20220360

Clinical characteristics of multi-inflammatory syndrome in children associated with COVID 19 at the time of first contact with a primary care physician: an observational study

Sreejith Kumar K. C., Kiran Kumar V. S.

Abstract


Background: MIS-C is a new clinical syndrome with many similarities with well-known common childhood illness. This present study aims to describe the clinical profile at the time of first contact with the primary care provider and to delineate it from other common illness.

Methods: Retrospective observational study in a referral hospital, GMC Thrissur, Kerala. All 43 diagnosed cases during the study period were enrolled. Data was retrieved from the case sheets and reference letters. Data was analysed in Statistical package for social sciences (SPSS) 20 software.

Results: 43 patients were diagnosed with MIS-C with a mean age at diagnosis was 7.3 years with a male preponderance. Fever was the universal symptom, gastrointestinal symptoms in 27 (62.7%), rash in 24 (55.8%), shock in 2 (4.6%), lymphadenopathy in 2, seizures in 2, altered sensorium in 1, palatal palsy in 1etc were the presenting symptoms. 12 (27.9%) of patients had no history of COVID 19 infection. The mean latency for MIS-C was 21 days (range 6-60 days). 17 (39.5%) patients developed shock later.

Conclusions: The symptom triad of fever, rash and gastrointestinal symptoms was the common presenting symptom at the first contact. Fever was present in all children. One third of patients had no history of symptomatic covid 19. Shock was the presenting symptom only in 2 (4.6%), but subsequently 17 (39.5%) children developed shock within 5 days of onset of symptoms. High index of suspicion and vigilance should be maintained by the primary care provider for the timely diagnosis and referral to higher centre.


Keywords


Clinical presentation, Multisystem inflammatory syndrome in children, Primary care, COVID-19, Shock

Full Text:

PDF

References


Qiu H, Wu J, Hong L, Luo Y, Son Q, Chen D. Clinical and epidemiological features of 36 children with coronavirus disease 2019 (COVID-19) in Zhejiang, China: an observational cohort study. The Lancet. Infect Dis. 2020;20(6):689-96.

Verdoni L, Mazza A, Gervasoni A, Martelli L, Ruggeri, Ciuffreda M et al. An outbreak of severe Kawasaki-like disease at the Italian epicentre of the SARS-CoV-2 epidemic: an observational cohort study. Lancet. 2020;395(10239):1771-8.

Jiang L, Tang K, Levin M, Irfan O, Morris SK, Bhutta ZA et al. COVID-19 and multisystem inflammatory syndrome in children and adolescents. The Lancet. Infect Dis. 2020;20(11):e276-88.

Multisystem inflammatory syndrome in children and adolescents with COVID-19 (2020) Scientific brief: World Health Organisation. Available at: https://www.who.int/publications-detail/multi-system-inflammatory-syndrome-in-children-andadolescents-with-covid-19. Accessed on 15 May 2020.

Health C for D and R. EUA Authorized Serology Test Performance. FDA. 2021. Accessed on 26 February 2021.

Belhadjer Z, Méot M, Bajolle F, Khraiche D, Legendre A, Abakka S et al Acute Heart Failure in Multisystem Inflammatory Syndrome in Children in the Context of Global SARS-CoV-2 Pandemic. Circulation. 2020;142(5):429-36.

Friedman KG, Harrild DM, Newburger JW. Cardiac Dysfunction in Multisystem Inflammatory Syndrome in Children: A Call to Action. Journal of the American College of Cardiology. 2020;76(17):1962-4.

Patel NA. Pediatric COVID-19: Systematic review of the literature. American journal of otolaryngology. 2020;41(5):102573.

Acevedo L, Piñeres-Olave BE, Niño-Serna LF, Vega LM, Gomez I, Chacón et al. Mortality and clinical characteristics of multisystem inflammatory syndrome in children (MIS-C) associated with covid-19 in critically ill patients: an observational multicenter study (MISCO study). BMC pediatrics. 2021;21(1):516.

Llinás-Caballero K, Rodríguez Y, Fernández-Sarmiento J, Rodríguez-Jiménez M, Anaya JM. Kawasaki disease in Colombia: A systematic review and contrast with multisystem inflammatory syndrome in children associated with COVID-19. Revista Colombiana de Reumatología. 2021.

Whittaker E, Bamford A, Kenny J, Kaforou M, Jone CE, Shah P et al Clinical Characteristics of 58 Children With a Pediatric Inflammatory Multisystem Syndrome Temporally Associated With SARS-CoV-2. JAMA. 2021;324(3):259-69.

Swann OV, Holden KA, Turtle L, Pollock L, Fairfield CJ, Drake et al. Clinical characteristics of children and young people admitted to hospital with covid-19 in United Kingdom: prospective multicentre observational cohort study. BMJ (Clinical research ed.). 2020;370:m3249.

Cruz AT, Zeichner SL. COVID-19 in Children: Initial Characterization of the Pediatric Disease. Pediatrics. 2020;145(6):e20200834.